Prolonged Survival of Acute Lymphoblastic Leukemia with Intrathecal Treatments for Isolated Central Nervous System Relapse

Acute lymphoblastic leukemia is commonly cured when diagnosed in the pediatric population. It portends a poorer prognosis if present in adult patients. Although adults frequently achieve complete remission, relapse rates are substantial, particularly among the elderly and high-risk populations. In t...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in hematology 2018-01, Vol.2018 (2018), p.1-3
Main Authors: Gorshein, Elan, Gharibo, Mecide, Kalathil, Sheila
Format: Article
Language:English
Subjects:
Acute lymphocytic leukemia
Blood
Bone marrow
Cancer
Cancer therapies
Case Report
Case reports
Cellular biology
Chemotherapy
Diagnosis
Diseases
Drug therapy
Family medical history
Flow cytometry
Hematology
Leukemia
Medical prognosis
Nervous system
Patients
Quality of life
Relapse
Stem cells
Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c501t-b6caf0503391f04dbd006c334930a1c37d2558ac6e4a3747a332be398710fdde3
cites cdi_FETCH-LOGICAL-c501t-b6caf0503391f04dbd006c334930a1c37d2558ac6e4a3747a332be398710fdde3
container_end_page 3
container_issue 2018
container_start_page 1
container_title Case reports in hematology
container_volume 2018
creator Gorshein, Elan
Gharibo, Mecide
Kalathil, Sheila
description Acute lymphoblastic leukemia is commonly cured when diagnosed in the pediatric population. It portends a poorer prognosis if present in adult patients. Although adults frequently achieve complete remission, relapse rates are substantial, particularly among the elderly and high-risk populations. In the absence of prophylactic intrathecal chemotherapy, more than half of patients may develop CNS involvement or relapse, which is associated with significant risk for systemic illness. This report describes a patient with acute lymphoblastic leukemia with repeated isolated CNS relapses. This case should remind clinicians that isolated CNS disease in the absence of systemic recurrence could successfully respond to intrathecal therapy and offer patients a favorable quality of life.
doi_str_mv 10.1155/2018/8765285
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_26be45610c0040bfa35ce748c5878b12</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A607535594</galeid><doaj_id>oai_doaj_org_article_26be45610c0040bfa35ce748c5878b12</doaj_id><sourcerecordid>A607535594</sourcerecordid><originalsourceid>FETCH-LOGICAL-c501t-b6caf0503391f04dbd006c334930a1c37d2558ac6e4a3747a332be398710fdde3</originalsourceid><addsrcrecordid>eNqNksFv0zAUhyMEYtPYjTOyxBG6Pcex41yQpmpApQoQG2fLcZ5blyQudtKp_PW4tHRU4oB9sGV_75N_8suylxSuKOX8Ogcqr2UpeC75k-w8hwomgpfV0-NewFl2GeMK0hCQM0afZ2d5JThlPD_Pfn4JvvX9AhtyN4aN2-iWeEtuzDggmW-79dLXrY6DM2SO43fsnCYPbliSWT8EPSzRpIL7gHrosB8isT6QWfStHpJxijuoJZ8wbPwYyd02DtiRr9jqdcQX2TOr24iXh_Ui-_b-9n76cTL__GE2vZlPDAc6TGphtAUOjFXUQtHUTQpiGCsqBpoaVjY551IbgYVmZVFqxvIaWSVLCrZpkF1ks7238Xql1sF1OmyV1079PvBhoXRIAVtUuaix4IKCASigtppxg2UhDZelrGmeXO_2rvVYd9iYfcAT6elN75Zq4TeKSwZVKZLg9UEQ_I8R46BWfgx9yq_y9EOV5BXAI7XQ6VWutz7JTOeiUTcCSs44r4pEXf2DSrNJ32R8j9al85OCt_sCE3yMAe3x4RTUrp_Urp_UoZ8S_urvsEf4T_ck4M0eWLq-0Q_uP3WYGLT6kaZFAVKwX-r2290</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2000985900</pqid></control><display><type>article</type><title>Prolonged Survival of Acute Lymphoblastic Leukemia with Intrathecal Treatments for Isolated Central Nervous System Relapse</title><source>PubMed Central（OA）</source><source>Wiley Online Library Open Access</source><source>Publicly Available Content Database</source><creator>Gorshein, Elan ; Gharibo, Mecide ; Kalathil, Sheila</creator><contributor>Gentile, Massimo ; Massimo Gentile</contributor><creatorcontrib>Gorshein, Elan ; Gharibo, Mecide ; Kalathil, Sheila ; Gentile, Massimo ; Massimo Gentile</creatorcontrib><description>Acute lymphoblastic leukemia is commonly cured when diagnosed in the pediatric population. It portends a poorer prognosis if present in adult patients. Although adults frequently achieve complete remission, relapse rates are substantial, particularly among the elderly and high-risk populations. In the absence of prophylactic intrathecal chemotherapy, more than half of patients may develop CNS involvement or relapse, which is associated with significant risk for systemic illness. This report describes a patient with acute lymphoblastic leukemia with repeated isolated CNS relapses. This case should remind clinicians that isolated CNS disease in the absence of systemic recurrence could successfully respond to intrathecal therapy and offer patients a favorable quality of life.</description><identifier>ISSN: 2090-6560</identifier><identifier>EISSN: 2090-6579</identifier><identifier>DOI: 10.1155/2018/8765285</identifier><identifier>PMID: 29651352</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Acute lymphocytic leukemia ; Blood ; Bone marrow ; Cancer ; Cancer therapies ; Case Report ; Case reports ; Cellular biology ; Chemotherapy ; Diagnosis ; Diseases ; Drug therapy ; Family medical history ; Flow cytometry ; Hematology ; Leukemia ; Medical prognosis ; Nervous system ; Patients ; Quality of life ; Relapse ; Stem cells ; Studies</subject><ispartof>Case reports in hematology, 2018-01, Vol.2018 (2018), p.1-3</ispartof><rights>Copyright © 2018 Elan Gorshein et al.</rights><rights>COPYRIGHT 2018 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2018 Elan Gorshein et al.; This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2018 Elan Gorshein et al. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c501t-b6caf0503391f04dbd006c334930a1c37d2558ac6e4a3747a332be398710fdde3</citedby><cites>FETCH-LOGICAL-c501t-b6caf0503391f04dbd006c334930a1c37d2558ac6e4a3747a332be398710fdde3</cites><orcidid>0000-0003-0989-7726</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2000985900/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2000985900?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29651352$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Gentile, Massimo</contributor><contributor>Massimo Gentile</contributor><creatorcontrib>Gorshein, Elan</creatorcontrib><creatorcontrib>Gharibo, Mecide</creatorcontrib><creatorcontrib>Kalathil, Sheila</creatorcontrib><title>Prolonged Survival of Acute Lymphoblastic Leukemia with Intrathecal Treatments for Isolated Central Nervous System Relapse</title><title>Case reports in hematology</title><addtitle>Case Rep Hematol</addtitle><description>Acute lymphoblastic leukemia is commonly cured when diagnosed in the pediatric population. It portends a poorer prognosis if present in adult patients. Although adults frequently achieve complete remission, relapse rates are substantial, particularly among the elderly and high-risk populations. In the absence of prophylactic intrathecal chemotherapy, more than half of patients may develop CNS involvement or relapse, which is associated with significant risk for systemic illness. This report describes a patient with acute lymphoblastic leukemia with repeated isolated CNS relapses. This case should remind clinicians that isolated CNS disease in the absence of systemic recurrence could successfully respond to intrathecal therapy and offer patients a favorable quality of life.</description><subject>Acute lymphocytic leukemia</subject><subject>Blood</subject><subject>Bone marrow</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Case Report</subject><subject>Case reports</subject><subject>Cellular biology</subject><subject>Chemotherapy</subject><subject>Diagnosis</subject><subject>Diseases</subject><subject>Drug therapy</subject><subject>Family medical history</subject><subject>Flow cytometry</subject><subject>Hematology</subject><subject>Leukemia</subject><subject>Medical prognosis</subject><subject>Nervous system</subject><subject>Patients</subject><subject>Quality of life</subject><subject>Relapse</subject><subject>Stem cells</subject><subject>Studies</subject><issn>2090-6560</issn><issn>2090-6579</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNksFv0zAUhyMEYtPYjTOyxBG6Pcex41yQpmpApQoQG2fLcZ5blyQudtKp_PW4tHRU4oB9sGV_75N_8suylxSuKOX8Ogcqr2UpeC75k-w8hwomgpfV0-NewFl2GeMK0hCQM0afZ2d5JThlPD_Pfn4JvvX9AhtyN4aN2-iWeEtuzDggmW-79dLXrY6DM2SO43fsnCYPbliSWT8EPSzRpIL7gHrosB8isT6QWfStHpJxijuoJZ8wbPwYyd02DtiRr9jqdcQX2TOr24iXh_Ui-_b-9n76cTL__GE2vZlPDAc6TGphtAUOjFXUQtHUTQpiGCsqBpoaVjY551IbgYVmZVFqxvIaWSVLCrZpkF1ks7238Xql1sF1OmyV1079PvBhoXRIAVtUuaix4IKCASigtppxg2UhDZelrGmeXO_2rvVYd9iYfcAT6elN75Zq4TeKSwZVKZLg9UEQ_I8R46BWfgx9yq_y9EOV5BXAI7XQ6VWutz7JTOeiUTcCSs44r4pEXf2DSrNJ32R8j9al85OCt_sCE3yMAe3x4RTUrp_Urp_UoZ8S_urvsEf4T_ck4M0eWLq-0Q_uP3WYGLT6kaZFAVKwX-r2290</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Gorshein, Elan</creator><creator>Gharibo, Mecide</creator><creator>Kalathil, Sheila</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0989-7726</orcidid></search><sort><creationdate>20180101</creationdate><title>Prolonged Survival of Acute Lymphoblastic Leukemia with Intrathecal Treatments for Isolated Central Nervous System Relapse</title><author>Gorshein, Elan ; Gharibo, Mecide ; Kalathil, Sheila</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c501t-b6caf0503391f04dbd006c334930a1c37d2558ac6e4a3747a332be398710fdde3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acute lymphocytic leukemia</topic><topic>Blood</topic><topic>Bone marrow</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Case Report</topic><topic>Case reports</topic><topic>Cellular biology</topic><topic>Chemotherapy</topic><topic>Diagnosis</topic><topic>Diseases</topic><topic>Drug therapy</topic><topic>Family medical history</topic><topic>Flow cytometry</topic><topic>Hematology</topic><topic>Leukemia</topic><topic>Medical prognosis</topic><topic>Nervous system</topic><topic>Patients</topic><topic>Quality of life</topic><topic>Relapse</topic><topic>Stem cells</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gorshein, Elan</creatorcontrib><creatorcontrib>Gharibo, Mecide</creatorcontrib><creatorcontrib>Kalathil, Sheila</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Case reports in hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gorshein, Elan</au><au>Gharibo, Mecide</au><au>Kalathil, Sheila</au><au>Gentile, Massimo</au><au>Massimo Gentile</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prolonged Survival of Acute Lymphoblastic Leukemia with Intrathecal Treatments for Isolated Central Nervous System Relapse</atitle><jtitle>Case reports in hematology</jtitle><addtitle>Case Rep Hematol</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>2018</volume><issue>2018</issue><spage>1</spage><epage>3</epage><pages>1-3</pages><issn>2090-6560</issn><eissn>2090-6579</eissn><abstract>Acute lymphoblastic leukemia is commonly cured when diagnosed in the pediatric population. It portends a poorer prognosis if present in adult patients. Although adults frequently achieve complete remission, relapse rates are substantial, particularly among the elderly and high-risk populations. In the absence of prophylactic intrathecal chemotherapy, more than half of patients may develop CNS involvement or relapse, which is associated with significant risk for systemic illness. This report describes a patient with acute lymphoblastic leukemia with repeated isolated CNS relapses. This case should remind clinicians that isolated CNS disease in the absence of systemic recurrence could successfully respond to intrathecal therapy and offer patients a favorable quality of life.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>29651352</pmid><doi>10.1155/2018/8765285</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-0989-7726</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2090-6560
ispartof Case reports in hematology, 2018-01, Vol.2018 (2018), p.1-3
issn 2090-6560
2090-6579
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_26be45610c0040bfa35ce748c5878b12
source PubMed Central（OA）; Wiley Online Library Open Access; Publicly Available Content Database
subjects Acute lymphocytic leukemia
Blood
Bone marrow
Cancer
Cancer therapies
Case Report
Case reports
Cellular biology
Chemotherapy
Diagnosis
Diseases
Drug therapy
Family medical history
Flow cytometry
Hematology
Leukemia
Medical prognosis
Nervous system
Patients
Quality of life
Relapse
Stem cells
Studies
title Prolonged Survival of Acute Lymphoblastic Leukemia with Intrathecal Treatments for Isolated Central Nervous System Relapse
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A28%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prolonged%20Survival%20of%20Acute%20Lymphoblastic%20Leukemia%20with%20Intrathecal%20Treatments%20for%20Isolated%20Central%20Nervous%20System%20Relapse&rft.jtitle=Case%20reports%20in%20hematology&rft.au=Gorshein,%20Elan&rft.date=2018-01-01&rft.volume=2018&rft.issue=2018&rft.spage=1&rft.epage=3&rft.pages=1-3&rft.issn=2090-6560&rft.eissn=2090-6579&rft_id=info:doi/10.1155/2018/8765285&rft_dat=%3Cgale_doaj_%3EA607535594%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c501t-b6caf0503391f04dbd006c334930a1c37d2558ac6e4a3747a332be398710fdde3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2000985900&rft_id=info:pmid/29651352&rft_galeid=A607535594&rfr_iscdi=true